Nektar Therapeutics (NASDAQ:NKTR)

About the company

Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

723

CEO

Howard W. Robin

Exchange

NASDAQ

Website

http://www.nektar.com

$137.00M

Total Revenue

723

Employees

$4B

Market Capitalization

-8.95

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$117M

Operating Margin (in %)

Total operating margin

$-408M

Net Margin (in %)

Total net margin

$-460M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 395981.84 82729.00 6.36 23.08 20.75
Merck & Co., Inc. MRK 200789.50 48081.00 7.54 19.81 21.10
Pfizer Inc. PFE 198619.60 50660.00 3.01 12.57 31.17
Eli Lilly & Co. LLY 148789.44 23087.00 50.49 26.23 23.97
AbbVie, Inc. ABBV 146723.08 34057.00 -23.48 17.50 24.65
Bristol Myers Squibb Co. BMY 108080.63 31006.00 2.62 91.89 3.08
Repligen Corp. RGEN 6248.01 286.00 5.99 272.24 8.11
Reata Pharmaceuticals, Inc. RETA 4635.12 20.00 21.96 -14.91 -150.30
Nektar Therapeutics NKTR 4111.36 137.00 3.21 -8.95 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3790.80 1.00 35.05 -5.80 None
Allakos, Inc. ALLK 3384.00 None 7.35 -36.18 None
OPKO Health, Inc. OPK 2460.36 891.00 1.75 -8.42 -32.92
Karuna Therapeutics, Inc. KRTX 2434.12 None 6.36 -60.01 None
ADC Therapeutics SA ADCT 2287.98 2.00 26.99 -19.62 None
Turning Point Therapeutics, Inc. TPTX 2233.08 None 6.72 -18.68 None
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Apellis Pharmaceuticals, Inc. APLS 2106.06 None 9.30 -5.05 None
Principia Biopharma, Inc. PRNB 1944.60 30.00 6.92 -27.67 -242.01
IGM Biosciences, Inc. IGMS 1943.08 None 8.56 -35.82 None
Springworks Therapeutics, Inc. SWTX 1554.02 None 5.05 -24.92 None
Y-mAbs Therapeutics, Inc. YMAB 1473.34 None 9.03 -15.99 None
Zymeworks, Inc. ZYME 1293.60 26.00 2.69 -7.62 -629.37
Tricida, Inc. TCDA 1263.22 None 6.49 -5.98 None
Akcea Therapeutics, Inc. AKCA 1188.25 341.00 2.44 -42.24 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1169.85 None 6.06 -9.67 None
Odonate Therapeutics, Inc. ODT 1147.24 None 9.40 -10.20 None
Phibro Animal Health Corp. PAHC 1057.80 818.00 5.34 28.67 4.49
Arcutis Biotherapeutics, Inc. ARQT 1046.73 None 4.46 -16.74 None
Akero Therapeutics, Inc. AKRO 1020.51 None 10.32 -20.11 None
Athenex, Inc. ATNX 938.34 123.00 5.76 -8.72 -87.86
Constellation Pharmaceuticals, Inc. CNST 913.92 None 4.30 -9.85 None
Gossamer Bio, Inc. GOSS 811.30 None 3.29 -4.08 None
G1 Therapeutics, Inc. GTHX 763.80 1.00 3.31 -5.83 None
Phathom Pharmaceuticals, Inc. PHAT 751.50 None 4.17 -2.76 None
Quanterix Corp. QTRX 744.12 60.00 6.56 -17.01 -71.52
Krystal Biotech, Inc. KRYS 681.87 None 3.98 -32.88 None
Amneal Pharmaceuticals, Inc. AMRX 672.67 1679.00 4.63 -3.09 -11.85
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Arcturus Therapeutics Holdings, Inc. ARCT 655.98 19.00 60.80 -23.58 -151.34
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Oric Pharmaceuticals, Inc. ORIC 647.64 None -7.03 -21.42 None
Applied Therapeutics, Inc. APLT 623.26 14.00 4.02 -12.65 -19.41
Aprea Therapeutics, Inc. APRE 602.91 None 5.34 -17.83 None
Keros Therapeutics, Inc. KROS 561.60 8.00 -25.37 -26.44 -285.35
Oyster Point Pharma, Inc. OYST 513.24 None 5.16 -8.92 None
SIGA Technologies, Inc. SIGA 482.16 19.00 5.39 -24.50 -94.00
Mirum Pharmaceuticals, Inc. MIRM 465.50 None 3.03 -6.87 None
Biospecifics Technologies Corp. BSTC 441.21 40.00 3.58 18.87 61.80
89bio, Inc. ETNB 435.68 None 5.37 -6.75 None
Satsuma Pharmaceuticals, Inc. STSA 417.01 None 4.10 -11.46 None
Fulcrum Therapeutics, Inc. FULC 406.18 1.00 6.84 -5.89 None
DURECT Corp. DRRX 398.04 28.00 30.57 -16.46 -82.94
Relmada Therapeutics, Inc. RLMD 377.82 0.00 5.63 -31.56 -877.66
Imara, Inc. IMRA 375.70 None 3.63 -10.68 None
Kala Pharmaceuticals, Inc. KALA 369.72 6.00 4.04 -4.03 None
TCR2 Therapeutics, Inc. TCRR 365.52 None 2.50 -36.26 None
Crinetics Pharmaceuticals, Inc. CRNX 365.04 1.00 4.61 -6.26 -447.78
Ocular Therapeutix, Inc. OCUL 353.04 6.00 -43.26 -3.85 None
Ovid Therapeutics, Inc. OVID 332.55 None 7.86 -5.10 None
Osmotica Pharmaceuticals Plc OSMT 332.37 232.00 2.52 -1.21 -115.44
Urovant Sciences Ltd. UROV 276.00 None -4.89 -1.91 None
IDEAYA Biosciences, Inc. IDYA 267.20 None 4.06 -6.13 None
Aeglea Biotherapeutics, Inc. AGLE 263.01 4.00 8.30 -3.28 -523.27
AMAG Pharmaceuticals, Inc. AMAG 261.80 321.00 1.00 -0.71 -115.05
Spero Therapeutics, Inc. SPRO 255.74 12.00 3.37 -3.14 -656.72
HOOKIPA Pharma, Inc. HOOK 255.58 13.00 2.31 -5.65 -333.02
Verrica Pharmaceuticals, Inc. VRCA 211.75 None 3.87 -6.94 None
KalVista Pharmaceuticals, Inc. KALV 208.08 13.00 2.46 -7.05 -229.44
Sutro Biopharma, Inc. STRO 201.02 41.00 3.82 -3.30 -148.06
Galera Therapeutics, Inc. GRTX 196.75 None 3.68 -2.99 None
Veru, Inc. VERU 189.15 39.00 6.47 -19.40 -25.53
Lannett Co., Inc. LCI 186.20 542.00 0.64 -6.13 -5.77
Kaleido Biosciences, Inc. KLDO 184.80 None 6.55 -2.52 None
LogicBio Therapeutics, Inc. LOGC 168.59 1.00 5.09 -3.96 None
Protara Therapeutics, Inc. TARA 160.02 None 2.41 -10.38 None
Avenue Therapeutics, Inc. ATXI 153.60 532.00 28.24 -10.55 26.69
Liquidia Technologies, Inc. LQDA 147.40 8.00 11.55 -2.99 -602.17
Gritstone Oncology, Inc. GRTS 144.72 4.00 1.30 -1.39 None
scPharmaceuticals, Inc. SCPH 140.41 119.00 3.59 -4.48 -27.05
Tyme Technologies, Inc. TYME 136.85 None 7.93 -6.26 None
Lyra Therapeutics, Inc. LYRA 133.92 1.00 -1.14 -8.03 -491.16
Harrow Health, Inc. HROW 132.86 51.00 8.52 -5.38 -47.54
Evelo Biosciences, Inc. EVLO 128.00 None 4.71 -1.46 None
Cyclerion Therapeutics, Inc. CYCN 127.44 6.00 1.61 -1.23 None
PhaseBio Pharmaceuticals, Inc. PHAS 127.02 2.00 2.35 -2.65 None
Ayala Pharmaceuticals, Inc. AYLA 126.48 3.00 -2.98 -6.13 -679.19
TFF Pharmaceuticals, Inc. TFFP 122.55 None 4.74 -3.16 None
Immunic, Inc. IMUX 121.10 None 3.56 -55.05 None
Mustang Bio, Inc. MBIO 120.40 None 2.81 -2.45 None
Aquestive Therapeutics, Inc. AQST 115.50 49.00 -6.65 -1.64 -139.64
NeuBase Therapeutics, Inc. NBSE 111.16 None 46.71 -2.49 None
Corvus Pharmaceuticals, Inc. CRVS 110.49 None 1.77 -2.34 None
Evolus, Inc. EOLS 94.50 45.00 1.69 -0.93 -217.51
Eton Pharmaceuticals, Inc. ETON 90.54 1.00 9.86 -4.53 None
Trevi Therapeutics, Inc. TRVI 88.56 None 1.88 -3.02 None
Milestone Pharmaceuticals, Inc. MIST 88.00 None 0.87 -1.41 None
EyePoint Pharmaceuticals, Inc. EYPT 77.93 26.00 5.50 -1.59 -196.30
Xeris Pharmaceuticals, Inc. XERS 76.72 4.00 3.81 -0.59 None
Clearside Biomedical, Inc. CLSD 71.34 6.00 9.16 -4.05 -293.61
Navidea Biopharmaceuticals, Inc. NAVB 67.83 1.00 -49.88 -6.14 -65.13
Checkpoint Therapeutics, Inc. CKPT 67.20 2.00 5.79 -2.90 -949.53
Aridis Pharmaceuticals, Inc. ARDS 67.05 1.00 -27.59 -2.29 -851.00
Baudax Bio, Inc. BXRX 60.66 None -1.65 -0.86 None
BiomX, Inc. PHGE 60.50 None 1.59 -1.41 None
Assertio Therapeutics, Inc. ASRT 60.29 192.00 1.05 -0.37 -83.99
Genprex, Inc. GNPX 56.24 None 4.77 -4.11 None
Aerpio Pharmaceuticals, Inc. ARPO 49.20 20.00 1.48 -2.61 -51.58
Menlo Therapeutics, Inc. MNLO 45.53 2.00 3.83 -0.49 -483.51
Edesa Biotech, Inc. EDSA 42.39 0.00 6.04 -0.45 -395.23
Eyenovia, Inc. EYEN 41.76 None 4.21 -2.04 None
Annovis Bio, Inc. ANVS 39.97 None 3.66 -31.72 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Moleculin Biotech, Inc. MBRX 36.11 None 3.14 -3.93 None
Adamis Pharmaceuticals Corp. ADMP 35.44 22.00 1.36 -1.20 -140.33
AgeX Therapeutics, Inc. AGE 34.83 2.00 -45.84 -2.86 -658.11
Citius Pharmaceuticals, Inc. CTXR 33.21 None 2.46 -1.92 None
Mannatech, Inc. MTEX 32.90 156.00 1.39 7.41 3.45
Acer Therapeutics, Inc. ACER 31.10 3.00 2.27 -1.19 -274.69
Allena Pharmaceuticals, Inc. ALNA 31.05 None 4.09 -0.71 None
Oncternal Therapeutics, Inc. ONCT 30.16 3.00 3.87 -1.20 -225.89
Daré Bioscience, Inc. DARE 28.88 1.00 12.67 -1.73 None
CNS Pharmaceuticals, Inc. CNSP 27.04 None 4.69 -4.97 None
Hoth Therapeutics, Inc. HOTH 26.20 None 7.28 -2.91 None
Millendo Therapeutics, Inc. MLND 25.65 0.00 0.60 -0.55 None
Aileron Therapeutics, Inc. ALRN 24.46 None 3.49 -0.92 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Spring Bank Pharmaceuticals, Inc. SBPH 22.40 0.00 0.85 -0.86 None
ProPhase Labs, Inc. PRPH 18.36 9.00 1.66 -6.12 -31.15
Novan, Inc. NOVN 14.62 5.00 -3.36 -0.46 -602.34
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
PDS Biotechnology Corp. PDSB 14.28 None 1.58 -0.56 None
Adial Pharmaceuticals, Inc. ADIL 13.20 None 3.22 -1.74 None
Titan Pharmaceuticals, Inc. TTNP 11.60 4.00 4.83 -0.64 -437.91
Novus Therapeutics, Inc. NVUS 7.20 None 0.62 -0.34 None
Brickell Biotech, Inc. BBI 4.22 5.00 1.38 -0.06 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Nektar Therapeutics wins dismissal of investor lawsuit over cancer drug

10h ago, source: Reuters

A federal judge has dismissed a proposed class action accusing Nektar Therapeutics Inc of misleading investors about the results of clinical trials examining the effectiveness of its flagship cancer ...

Nektar Therapeutics NKTR

7d ago, source: Morningstar%2c Inc.

No-moat Nektar Therapeutics reported first-quarter results mostly in line with our expectations, with $51 million in revenue from milestones and royalties and, aside from a $45 million impairment ...

Interesting NKTR Call Options For August 28th

5d ago, source: Nasdaq

Investors in Nektar Therapeutics (Symbol: NKTR) saw new options become available today, for the August 28th expiration. At ...

Nektar Therapeutics (NASDAQ:NKTR) Shares Purchased by New Mexico Educational Retirement Board

13d ago, source: modernreaders.com

New Mexico Educational Retirement Board increased its stake in shares of Nektar Therapeutics (NASDAQ:NKTR) by 38.7% in the ...

Hedge Funds Aren’t Impressed By Nektar Therapeutics (NKTR)

21d ago, source: YAHOO!

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold ...

Medicenna Company Update And Upcoming Catalysts

Opinion ago, source: Seeking Alpha

Medicenna's IL-2 engineered Superkine MDNA11 recently replaced MDNA19 as Medicenna's potential best-in-class IL2 candidate to ...

IPO Preview: Pandion Therapeutics Starts $75 Million IPO Effort

11d ago, source: TheStreet.com

Pandion Therapeutics (PAND) intends to raise $75 million in an IPO of its common stock, according to an S-1 registration statement. The company is developing drug candidates to treat various ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.